Selected Publications

Brian G Feagan, Bruce E Sands, William J Sandborn, Matthew Germinaro, Marion Vetter, Jie Shao, Shihong Sheng, Jewel Johanns, Julián Panés: Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial. Lancet Gastroenterol Hepatol 8(4): 307-320, Apr 2023.

Sandborn WJ, D'Haens GR, Reinisch W, Panés J, Chan D, Gonzalez S, Weisel K, Germinaro M, Frustaci ME, Yang Z, Adedokun OJ, Han C, Panaccione R, Hisamatsu T, Danese S, Rubin DT, Sands BE, Afzali A, Andrews JM, Feagan BG; GALAXI-1 Investigators.: Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology 162(6): 1650-1664.e8. May 2022.

Dreskin SC, Germinaro M, Reinhold D, Chen X, Vickery BP, Kulis M, Burks AW, Negi SS,Braun W, Chambliss J, Eglite S, McNulty CMG.: IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy. Pediatr Allergy Immunol 30(8): 817-823, Dec 2019.

Weinstein SF, Katial RK, Bardin P, Korn S, McDonald M, Garin M, Bateman ED, Hoyte FCL, Germinaro M.: Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract 7(2): 589-596.e3, Feb 2019.

Bateman ED, Djukanovic R, Castro M, Canvin J, Germinaro M, Noble R, Garin M, Buhl R.: Predicting Responders to Reslizumab After 16 Weeks of Treatment Using an Algorithm Derived From Clinical Studies of Patients with Severe Eosinophilic Asthma. Am J Respir Crit Care Med 199(4): 489-495, Feb 2019.

Brusselle G, Germinaro M, Weiss S, Zangrilli J.: Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils. Pulm Pharmacol Ther 43: 39-45, Apr 2017.

Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M.: Reslizumab for Inadequately Controlled Asthma with Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study. CHEST 150(4): 789-798, Oct 2016.

Germinaro, M., Reynolds, P., Knight, V., Alam, R.: Association of B-cell activating factor receptor deficiency with the P21R polymorphism and common variable immunodeficiency. Ann Allergy Asthma Immunol 115(1): 82-83, Jul 2015.

Zeng G, Germinaro M, Micsenyi A, Monga NK, Bell A, Sood A, Malhotra V, Sood N, Midda V, Monga DK, Kokkinakis DM, Monga SP: Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma. Neoplasia 8(4): 279-289, Apr 2006.

Monga SP, Micsenyi A, Germinaro M, Apte U, Bell A.: beta-Catenin regulation during matrigel-induced rat hepatocyte differentiation. Cell and Tissue Research 323(1): 71-79, Jan 2006.